Debt-relief talks restart in Greece (AP)

ATHENS, Greece ? Greece's prime minister resumed talks late Thursday with top bank negotiators to try and overcome obstacles to a major debt-relief deal needed to avoid bankruptcy.

Premier Lucas Papademos met with Charles Dallara, managing director of the Institute of International Finance, a banking lobby, and Jean Lemierre, senior adviser to the chairman of French bank BNP Paribas.

Private bondholders are being asked to forgive half their Greek debt, and in return accept cash payments and new bonds with longer maturities. The deal is required for a second international bailout with a looming euro14.5 billion bond repayment on March 20 that carries a serious threat of bankruptcy for Greece.

Top eurozone officials are pressing private bondholders to accept the new bonds at a lower interest rate.

A senior Greek government official said, despite delays in concluding the negotiations, Greece was still aiming to submit its formal offer for the bond-swap deal to banks and other private creditors by Feb. 13. The official asked not to be named because the talks are ongoing.

Dallara resumed the talks in Athens for a third successive week.

Eurozone countries have taken a tough stance with the IIF because they would have to provide additional help to Greece if the bond-swap deal falls short of expectations.

"To ensure debt sustainability for Greece, it is essential that a new program be supported by a combination of private sector involvement and official sector support," William Murray, an IMF spokesman, said late Wednesday.

Murray said the IMF has not asked the European Central Bank, which holds more than euro40 billion ($52 billion) in Greek government bonds, to play any specific role in relieving Greece's debt pile.

The ECB, as a public sector holder of Greek debt, is protected from any writedown.

"The Fund has no view on the relative contribution of private sector involvement and official sector support in achieving" the target of cutting Greece's debt-to-GDP ratio to 120 percent, Murray said.

Greece is currently surviving on a euro110-billion loan package from eurozone countries and the International Monetary Fund, and has been promised an additional euro130 billion in rescue aid if the bond-swap deal goes through.

EU-IMF debt inspectors are currently in Athens for talks with the Papademos government, to set conditions for the second package that are expected to produce more austerity measures in the recession-hit country.

Hardship facing many Greeks has spurred a huge drop in support for the country's Socialist party, which won the last general election in 2009 with nearly 44 percent of the vote, and formed a coalition government with rival conservatives two months ago.

A nationwide opinion poll published Thursday found support for the Socialists has dropped to 12 percent, just behind three opposition left-wing parties.

The VPRC survey for the Epikaira news magazine gave the conservatives 30.5 percent support. Sample data was not immediately available.

General elections are expected in late April.

___

Nicholas Paphitis and Nektina Efthymiou contributed.

Source: http://us.rd.yahoo.com/dailynews/rss/business/*http%3A//news.yahoo.com/s/ap/20120126/ap_on_bi_ge/eu_greece_financial_crisis

weather chicago swizz beatz mpaa nightline south carolina debate lauren scruggs william shatner

Skrillex, 12th Planet Play To Sold-Out L.A. Crowd

Skrill's high-energy gig with Diplo was part of six-show EDM series in Los Angeles.
By Lara Kathleen Kelley


Skrillex and 12th Planet perform in Los Angeles
Photo: Michelle Oglakhchyan

It's officially Skrillex week in Los Angeles, where MTV's EDM Artist of the Year just finished his second gig in a series of six back-to-back shows, each spotlighting diverse talent in the now-reigning dubstep scene. Wednesday night's gig at CYP2, a popular bi-weekly indie dance music event, featured Skrillex performing a back-to-back set with 12th Planet, Diplo and UK producer Caspa for a jam-packed crowd at the Echoplex.

"The show sold out in under 20 minutes," said Danny Johnson, co-producer of CYP2. "Skrillex and 12th Planet are best buds, Caspa is a dubstep don and Diplo has championed these artists from day one, so the lineup made perfect sense and the fans went crazy for it."

As soon as the doors opened, partygoers piled in, energy high and anticipation permeating the air. Music pumped from the speakers by DJ Franki Chan, owner of the IHeartComix label and CYP2 co-producer. Then DJ/producer Diplo lit up the crowd with bass-heavy beats and hard-core hip-hop tracks. But it wasn't until Skrillex took the stage with 12th Planet that the fans went crazy and began screaming, chanting and moshing for the dubstep duo.

Skrillex pumped up the fans and held them at his fingertips with tracks like "Breakin' a Sweat" and "Right on Time." The set included all of their popular singles as well as remixes of Avicii's "Levels," La Roux's "In for the Kill" and Rusko's "Hold On." Their two-and-a-half-hour set kept the crowd on their feet and begging for more bass until the lights came on.

12th Planet, born John Dadzie, had nothing but great things to say about the five-time Grammy-nominated artist formerly known as Sonny Moore.

"Skrillex and I met at Ultra Music Festival a few years ago and have been good friends ever since," he said. "We started doing collaborations together, and he would sing vocals during my sets. Since then, Skrillex has become a beast, and now when I get the opportunity to work with him, I learn as much as I possibly can. 12th Planet, recently deemed "U.S. dubstep godfather" by dance-music magazine Mixmag, spent much of 2011 on tour with Skrillex. "Performing with Skrillex reminds me of how much fun it is to tag-team DJ with one of your good friends. I love the chemistry that comes together when I play with Skrillex ... we can pretty much connect by E.S.P. during our sets."

Just this month, 12th Planet released his five-track free-for-download The End Is Near. It will be complimented by a 28-city North American tour that kicks off on February 2 in Miami, Florida.

The week-long Skrillex takeover continues with a show Thursday (January 26) night at the Exchange in Downtown L.A. followed by massive gigs at the Avalon in Hollywood Friday night, the Palladium on Saturday and L.A. Live on Sunday. Next week heads to New York for a series of dates, kicking off at Webster Hall on Tuesday.

Are you planning on seeing Skrillex live? Let us know in the comments!

Related Videos Related Artists

Source: http://www.mtv.com/news/articles/1677941/skrillex-12th-planet-cyp2-los-angeles.jhtml

girl with the dragon tattoo hes just not that into you hes just not that into you monta ellis kawasaki disease mega millions emma stone

Morgan Stanley CEO sees better markets in 2012 (Reuters)

NEW YORK (Reuters) ? Capital markets in 2012 are better than they were in 2011, Morgan Stanley Chief Executive James Gorman said on Wednesday, adding that his bank is in a "very good position for Basel III standards."

Gorman, speaking to CNBC from Davos, Switzerland, said confidence will rise after euro zone stability improves, while stressing that Morgan Stanley (MS.N) is in a very solid position. "If you had all sovereigns, all corporates and all financial institutions blow up in Europe at the same time, Morgan Stanley would still be fine," he said.

Gorman also said Morgan Stanley would not need to raise capital in the near term. Morgan Stanley's capital levels have been a concern for investors because it will need to comply with new, stricter rules set by the Basel Committee and U.S. regulators.

The Basel III accord, agreed to by the Basel Committee, an international group of regulators, will require banks to hold at least 7 percent of core Tier 1 capital in the form of retained earnings or pure equity.

There are also concerns because Morgan Stanley may need a big chunk of cash to purchase the next stake of its Morgan Stanley Smith Barney venture from Citigroup Inc (C.N).

Morgan Stanley currently owns 51 percent of the wealth management business and has the option to buy another 14 percent in May at fair market value. Gorman reiterated his commitment to buy the business on Wednesday, a purchase he said will take a priority over stock buybacks or dividends in the near-term.

(Reporting by Sam Forgione and Lauren LaCapra; Editing by Leslie Adler)

Source: http://us.rd.yahoo.com/dailynews/rss/business/*http%3A//news.yahoo.com/s/nm/20120125/bs_nm/us_euro_zone_banks

black friday 2011 rhodium uppity uppity stuffing brandon mcinerney brandon mcinerney

Iranian film in running for foreign language Oscar (AP)

LONDON ? Their settings span the globe, but this year's foreign-language Academy Award nominees are united in giving local stories a universal resonance.

The five finalists range from World War II Poland to modern-day Israel and Quebec, from an Iranian divorce court to the bruising world of Belgian cattle-rearing.

Front-runner among the contenders announced Tuesday in Los Angeles is "A Separation," the story of a marital breakdown and its far-reaching consequences from Iranian writer-director Asghar Farhadi.

The widely praised film ? hailed by some as a vital cultural bridge at a time of souring relations between Iran and the West ? has already won the Golden Globe for best foreign language film, and also gained Farhadi an Oscar nomination for best original screenplay.

Farhadi said in a statement that it was a very personal project ? a sentiment echoed by other nominated filmmakers.

"For a long time I had this picture carved inside my head," he said. "I don't know how it got there, but once it was there I just knew I had to make this film and here we are today with not one but two nominations."

"A Separation" is up against four other films, including "Footnote," a mordant tale of rivalry between father-son Talmudic scholars by Israel's Joseph Cedar.

Cedar said there was "something poetic" in the fact that Israeli and Iranian films were both nominated. The two countries are bitter enemies, and Israel has been a leading voice in international calls to halt Iran's nuclear program.

Cedar, who was Oscar nominated in 2008 for "Beaufort," said it was "very flattering" to be nominated in what he called "a great year for foreign film at the Oscar."

Lior Ashkenazi, who plays the son, said he was shocked to hear the film had been nominated given its subject ? "two Talmudic scholars, the most drab thing that could be."

"Who could imagine it?" he told Israel Radio. "It's not exactly an action movie."

Israel has emerged as a surprising powerhouse in the foreign film category, garnering four Oscar nominations since 2007. Two of those nominations have gone to Cedar.

Belgian director Michael R. Roskam gained a nomination for his feature debut "Bullhead," a crime drama set in the world of cattle rearing and hormone dealing.

Producer Bart Van Langendonck welcomed the recognition for a film that "was written so it could be appreciated all over the world, even if the theme of the cattle mafia is extremely Belgian."

The nominees also include the gritty, realistic "In Darkness" by Poland's Agnieszka Holland, based on the true story of Leopold Socha, a Polish petty criminal who hid Jews from the Nazis in the sewage canals of Lviv during World War II.

Holland uses the character to explore the ambiguous attitudes of Poles toward Jews during the Nazi occupation of their country. Some Poles were deeply anti-Semitic and helped the Nazis track down Jews for extermination, but others risked to own lives to help Jews.

The director dedicated the film to the more than 6,000 Poles, including Socha, named by Israel's Yad Vashem Holocaust memorial as "Righteous Among the Nations," an honor reserved for non-Jews who risked their lives to save Jews.

It's a third Oscar nomination for 63-year-old Holland, one of the country's best-known directors, after "Europa Europa" and "Angry Harvest," both of which also dealt with the Holocaust.

Holland said she felt the nomination defied a "stereotype" that everything has already been said about the Holocaust.

"People react emotionally both in Poland and in the United States. And afterward, the film goes from the heart to the mind and awakens thoughts," she told news channel TVN24. "People feel the film is enriching."

The fifth contender is "Monsieur Lazhar," Canadian director Philippe Falardeau's story of an Algerian immigrant substitute teacher who helps a group of children get over a death.

It's the second straight year a filmmaker from Quebec has made the shortlist. Denis Villeneuve was nominated last year for his war drama "Incendies."

Falardeau said he was overwhelmed by the recognition for the French-language film, adapted from a play by Evelyne de la Cheneliere.

The director likened himself to "a hockey player trying to describe the feeling after he wins the Stanley Cup ? he looks stupid because it is indescribable and unbelievable."

"So there you are: indescribable and unbelievable," he said.

"I think I rejoice myself in the fact that an intimate film like 'Monsieur Lazhar' can exist alongside major Hollywood productions in the biggest gala in the world," Falardeau said. "I think it says a lot about the fact that we have to make the movie that we have inside of us and not try to imitate any kind of recipe."

But he admitted the looming ceremony left him with a dilemma ? "I don't have a tux."

This year's Oscars contest already has an international flavor. The race is led by Martin Scorsese's Parisian fantasia "Hugo," with 11 nominations, and "The Artist," a French-made silent tale of old Hollywood, with 10.

Winners of the 84th annual Oscars will be announced at a Feb. 26 ceremony at Hollywood's Kodak Theatre.

___

Associated Press writers Raf Casert in Antwerp, Belgium, Vanessa Gera in Warsaw, Ian Deitch in Jerusalem and Rob Gillies in Toronto contributed to this report.

____

Online: http://www.oscars.org

Source: http://us.rd.yahoo.com/dailynews/rss/celebrity/*http%3A//news.yahoo.com/s/ap/20120124/ap_on_en_mo/eu_oscar_nominations_foreign_films

ehlers danlos syndrome band of brothers the closer michael turner split pea soup land of the lost cleveland cavaliers

Insurer WellPoint's 4Q profit sinks 39 percent (AP)

INDIANAPOLIS ? WellPoint Inc.'s fourth-quarter profit sank 39 percent as investment income fell and the amount it paid in medical claims soared, but the health insurer raised its quarterly dividend and said it expects earnings growth in 2012.

The largest health insurer based on enrollment said Wednesday it earned $335.3 million, or 96 cents per share, in the three months that ended Dec. 31. That's down from $548.8 million, or $1.40 per share, in the final quarter of 2010. Adjusted net income, which excludes investment gains and losses, was 99 cents per share.

Operating revenue, which also excludes investment income or gains, climbed 5.5 percent to $15.18 billion.

The performance led to a rare miss of Wall Street expectations. Analysts surveyed by FactSet expected, on average, earnings of $1.12 per share on $15.46 billion in revenue.

The Indianapolis company said medical claims, its largest expense, climbed nearly 10 percent in the quarter to $12.43 billion. In contrast, that expense fell 5 percent in the 2010 quarter. The change was driven largely by expenses tied to a California Medicare Advantage plan, WellPoint spokeswoman Kristin Binns said.

Binns also said the insurer recorded a benefit of $350 million in the 2010 quarter because claims left over from previous quarters came in lower than expected. It had no gain like that in the 2011 quarter.

Managed care companies also have been buoyed by health care use that has grown at lower-than-expected rates for the past few quarters. This trend, which may be driven by a lingering pullback on consumer spending from the recession, has helped companies consistently beat analyst expectations. Analysts have said they expect this trend to continue, but insurers say they see signs that health care use is picking up.

WellPoint competitor UnitedHealth Group Inc. said last week that growth rates still remained slower than what the industry saw before the recession, but it expects use of health care to increase steadily throughout 2012.

WellPoint said Wednesday its board approved a quarterly dividend of 28.7 cents per share that will be paid March 23 to shareholders of record on March 9.

The insurer also said expects to earn at least $7.60 per share in 2012, which would represent growth of more than 8 percent over 2011.

WellPoint operates Blue Cross Blue Shield plans in 14 states, including California, New York and Ohio.

Source: http://us.rd.yahoo.com/dailynews/rss/earnings/*http%3A//news.yahoo.com/s/ap/20120125/ap_on_bi_ge/us_earns_wellpoint

when does daylight savings time end world series mvp rocky horror picture show risky business weather nj weather nj nyc weather

95% Pina

All Critics (63) | Top Critics (17) | Fresh (59) | Rotten (3) | DVD (1)

What the filmmaker has created is an inspired simulacrum - a jewel-box that contains more of Bausch's kinetic soul than film has any right to.

Crane and steadycam allow Wenders to get so close to the action that in the minimalist Caf? M?ller, one's illusion of being on stage is uncanny.

"Pina"is the best possible tribute to Bausch, and to adventurous image-making.

I watched the film in a sort of reverie.

Whether you're familiar with Pina Bausch's work or not, the new film "Pina" is a knockout.

So this is what 3-D is capable of when used for art rather than the commerce of hiking ticket prices and repurposing cartoons!

Even for someone who would rather count sheep than attend a ballet, these scenes are nothing short of astonishing, beautifully presenting dance's ability to depict words.

You won't hear the names Merce Cunningham, Martha Graham, Paul Taylor or Bob Fosse breathed herein.

An exhilarating experience, both in its celebration of Bausch's groundbreaking work and in the thrilling way that Wenders captures it on camera.

It's not an overview of Bausch's career or a statement on her art, but a celebration of her work and the dancers who bring it to life.

This is a stunning film, a glorious homage to modern dance and one of its premier authors and the best justification of 3D technology to date.

With a breakout use of 3D for artistic rather than solely commercial blockbuster purposes, German director Wim Wenders gives extraordinary life to the work of choreographer Pina Bausch.

From the hauntingly beautiful to the scary, Pina Bausch's post-modern dance sparkles in 3D.

It's an enchanting film, one that makes you feel you are missing something dear if you don't dance or appreciate it as an art form.

An often exhilarating, lively, magical and breathtaking experience of Pina Bausch's art.

A welcome departure from the by-the-numbers fossilization in today's documentary deluge.

Thanks to 3D technology it's dance film quite unlike any other, which was filmmaker Wim Wenders' intention, and it's a transporting experience for the uninitiated and the cognoscenti alike.

More Critic Reviews

No quotes approved yet for Pina. Logged in users can submit quotes.

Submit A Quote

Source: http://www.rottentomatoes.com/m/pina_3d/

anniversary god bless america flight 93 flight 93 al qaeda infiniti empire state building

From the Tips Box: Windows Explorer Sorting, Gift Card Balances, and Linux Package Managers [From The Tips Box]

Readers offer their best tips for sorting files in Windows Explorer, managing gift card balances, and speeding through Linux installations.

Don't like the gallery layout? Click here to view everything on one page.

Every day we receive boatloads of great reader tips in our inbox, but for various reasons?maybe they're a bit too niche, maybe we couldn't find a good way to present it, or maybe we just couldn't fit it in?the tip didn't make the front page. From the Tips Box is where we round up some of our favorites for your buffet-style consumption. Got a tip of your own to share? Add it in the comments, email it to tips at lifehacker.com, or share it on our tips and expert pages.

Source: http://feeds.gawker.com/~r/lifehacker/full/~3/HgiJuqD-1Mg/

jessica sutta sexiest man alive 2011 ruben studdard ruben studdard black friday sales 2011 black friday sales 2011 whitney duncan

La Jolla Institute scientist takes quest to conquer Type 1 diabetes to the next level

[ Back to EurekAlert! ] Public release date: 23-Jan-2012
[ | E-mail | Share Share ]

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Renowned researcher to lead new translational center

SAN DIEGO (January 23, 2012) La Jolla Institute scientist Matthias von Herrath, M.D., a world leader in basic research on type 1 diabetes, has long dreamed of seeing his discoveries translated into new therapies to better treat this serious and chronic disorder. Dr. von Herrath may soon get his chance as head of a new translational type 1 diabetes center to be opened in Seattle in 2012 by Novo Nordisk, a global healthcare company specializing in diabetes care. Dr. von Herrath will continue to lead his vibrant and renowned research program at the La Jolla Institute for Allergy & Immunology on a part-time basis.

"We are excited by the opportunities that this dual appointment will provide Dr. von Herrath to take his discoveries to the next level clinical development," said Mitchell Kronenberg, Ph.D., La Jolla Institute president & chief scientific officer. "As a nonprofit biomedical research institute, our mission is to find the molecular causes of diseases, with the hope that our discoveries will one day be translated into new and better therapies. This is an important step toward that goal."

Dr. Jacob Sten Petersen, Novo Nordisk corporate vice president, said the new translational center will be based on an innovative strategic concept to move early stage discovery projects rapidly from mouse models into small clinical exploration trials in type 1 diabetes patients. "The primary goal of this initiative is to find new, innovative ways to treat people with type 1 diabetes," he said, adding that the Center is planned to open this summer.

The company sought Dr. von Herrath to lead the Center due to his stellar record in type 1 diabetes research. "Dr. von Herrath is generally regarded as one of the top researchers in the world in type 1 diabetes," said Dr. Petersen. "He has made several key advances and is the kind of dedicated, talented researcher that can fuel true innovation in type 1 diabetes treatment." Dr. von Herrath is the recipient of the Juvenile Diabetes Research Foundation's prestigious Scholar Award and in 2008 received the Outstanding Scientific Achievement Award from the American Diabetes Association.

The Center will focus on the development of type 1 diabetes immunotherapies, an area where Dr. von Herrath has specialized expertise. "My dream has always been to see the most promising immune-based interventions translated into better treatments for patients with diabetes," he said. "As head of the translational center, I will have an opportunity to pursue this dream, as well as forge new public-private collaborations to access other novel research ideas for potential development into better treatment options for people with type 1 diabetes."

Dr. Kronenberg said Novo Nordisk has the kind of strong biopharmaceutical development infrastructure that is necessary to take discoveries from research laboratories, into human clinical trials, and, if successful, into approved drugs. "By establishing this relationship with Novo Nordisk, Dr. von Herrath is accelerating an important and complementary process that is strongly supported by this Institute; one that moves discoveries toward becoming treatments available to patients," he said. "We are pleased that Dr. von Herrath has entered into this exciting endeavor, while at the same time maintaining his laboratory and research efforts at our Institute. Clearly, this type of arrangement is a win-win for the scientific community and for patients."

Based in Denmark, Novo Nordisk has a longstanding history in type 1 diabetes treatment and markets several drugs for diabetes sufferers worldwide. Globally, about 6,000 people work on the company's research and development activities.

###

About La Jolla Institute

Founded in 1988, the La Jolla Institute for Allergy & Immunology is a biomedical research nonprofit focused on improving human health through increased understanding of the immune system. Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer, inflammatory and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma. La Jolla Institute's research staff includes more than 150 Ph.D.s and M.D.s. To learn more about the Institute's work, visit www.liai.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


[ Back to EurekAlert! ] Public release date: 23-Jan-2012
[ | E-mail | Share Share ]

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Renowned researcher to lead new translational center

SAN DIEGO (January 23, 2012) La Jolla Institute scientist Matthias von Herrath, M.D., a world leader in basic research on type 1 diabetes, has long dreamed of seeing his discoveries translated into new therapies to better treat this serious and chronic disorder. Dr. von Herrath may soon get his chance as head of a new translational type 1 diabetes center to be opened in Seattle in 2012 by Novo Nordisk, a global healthcare company specializing in diabetes care. Dr. von Herrath will continue to lead his vibrant and renowned research program at the La Jolla Institute for Allergy & Immunology on a part-time basis.

"We are excited by the opportunities that this dual appointment will provide Dr. von Herrath to take his discoveries to the next level clinical development," said Mitchell Kronenberg, Ph.D., La Jolla Institute president & chief scientific officer. "As a nonprofit biomedical research institute, our mission is to find the molecular causes of diseases, with the hope that our discoveries will one day be translated into new and better therapies. This is an important step toward that goal."

Dr. Jacob Sten Petersen, Novo Nordisk corporate vice president, said the new translational center will be based on an innovative strategic concept to move early stage discovery projects rapidly from mouse models into small clinical exploration trials in type 1 diabetes patients. "The primary goal of this initiative is to find new, innovative ways to treat people with type 1 diabetes," he said, adding that the Center is planned to open this summer.

The company sought Dr. von Herrath to lead the Center due to his stellar record in type 1 diabetes research. "Dr. von Herrath is generally regarded as one of the top researchers in the world in type 1 diabetes," said Dr. Petersen. "He has made several key advances and is the kind of dedicated, talented researcher that can fuel true innovation in type 1 diabetes treatment." Dr. von Herrath is the recipient of the Juvenile Diabetes Research Foundation's prestigious Scholar Award and in 2008 received the Outstanding Scientific Achievement Award from the American Diabetes Association.

The Center will focus on the development of type 1 diabetes immunotherapies, an area where Dr. von Herrath has specialized expertise. "My dream has always been to see the most promising immune-based interventions translated into better treatments for patients with diabetes," he said. "As head of the translational center, I will have an opportunity to pursue this dream, as well as forge new public-private collaborations to access other novel research ideas for potential development into better treatment options for people with type 1 diabetes."

Dr. Kronenberg said Novo Nordisk has the kind of strong biopharmaceutical development infrastructure that is necessary to take discoveries from research laboratories, into human clinical trials, and, if successful, into approved drugs. "By establishing this relationship with Novo Nordisk, Dr. von Herrath is accelerating an important and complementary process that is strongly supported by this Institute; one that moves discoveries toward becoming treatments available to patients," he said. "We are pleased that Dr. von Herrath has entered into this exciting endeavor, while at the same time maintaining his laboratory and research efforts at our Institute. Clearly, this type of arrangement is a win-win for the scientific community and for patients."

Based in Denmark, Novo Nordisk has a longstanding history in type 1 diabetes treatment and markets several drugs for diabetes sufferers worldwide. Globally, about 6,000 people work on the company's research and development activities.

###

About La Jolla Institute

Founded in 1988, the La Jolla Institute for Allergy & Immunology is a biomedical research nonprofit focused on improving human health through increased understanding of the immune system. Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer, inflammatory and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma. La Jolla Institute's research staff includes more than 150 Ph.D.s and M.D.s. To learn more about the Institute's work, visit www.liai.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-01/ljif-lji012012.php

darrell hammond boxer rebellion boxer rebellion stanford football lsu football schedule lsu football schedule terrapin

Study: 'Tiger Parenting' Tough on Kids (LiveScience.com)

"Tiger mom" and Yale professor Amy Chua caused an uproar last year with a Wall Street Journal article about the superiority of her strict, Chinese-style version of parenting. Now, research suggests that critics of the piece may have had a point: High-achieving Chinese-American children do, in fact, struggle more with depression, stress and low self-esteem than their equally high-achieving European-American counterparts, and the reason involves parenting style.

Chua's piece, excerpted from her book "Battle Hymn of the Tiger Mother" (Penguin Press, 2011), extolled the virtues of strictness, blunt criticism and an unyielding insistence on academic perfection. In the essay, she tells the story of making her 7-year-old daughter sit at the piano without food or bathroom breaks until she mastered a difficult piece.

Strict parenting and stellar academic achievement are common in Chinese immigrant families, according to Desiree Baolian Qin, a professor in the department of human development and family studies at Michigan State University. But unfortunately, so are depression, stress and other so-called "internalizing" disorders.

"If you're doing well, you should be feeling good," Qin told LiveScience. "But what I've found persistently in my research is that that's not the case."

Family and mental health

In a new study to be published in the Journal of Adolescence, Qin compared 295 Chinese-American ninth graders with 192 European-American ninth-graders at the same highly competitive U.S. school. This high school, in a northeastern U.S. state, accepts only the top 5 percent of applicants by test scores. Thus, all the children in the study were academic all-stars.

Earlier research had turned up disturbing patterns of mental health struggles in Chinese-American high-achievers, Qin said. She wanted to understand why. So she and her colleagues had the two groups of ninth graders fill out questionnaires to measure their grades, levels of anxiety and depression and the amount of conflict in their families. The researchers also asked about how much warmth and support they felt from their parents, a measure called family cohesion.

"It wasn't completely surprising, but I was still a little shocked that in all these measures of family conflicts and cohesion and mental health, we see the Chinese kids were more disadvantaged," Qin said. "They reported higher levels of conflict, particularly around education, and they report much lower levels of cohesion." [7 Things That Will Make You Happy]

Not only that, but they were more stressed and depressed than the Euro-American counterparts, and they had lower self-esteem.

The culprit, Qin found, had everything to do with family. The more conflict and less cohesion in a teen's family, the more likely they were to have poor mental health. When the researchers removed conflict and cohesion from the statistical analysis, essentially erasing those differences between the white and Asian kids, the mental health difference also disappeared.

"Parent-child relations are the main factors that contribute to their lower levels of reported mental health," Qin said.

Academic strife

In a second study, Qin conducted in-depth interviews with18 of the Chinese students at the school. She found that academics are an enormous point of contention in Chinese-American families. The students complained that their parents talked constantly about academics and reacted emotionally to failure.

"They just take everything so literally, and exaggerate," one female student told Qin, "like if I get one bad grade, they think, 'Oh no, you're going to fail school, you're going to become one of those bad girls who do drugs.'"

Students also struggled with being compared to other children or family members, such as an older sibling who went to an Ivy League college. They even mentioned struggling with a cultural gulf between themselves and their parents. For example, one student said that she had a tough time in her relationship with her mother because American culture values standing up for oneself, while her Chinese-born mother feels that children should respect their parents and do as they're told.

While East Asian culture has a deeply ingrained focus on education, many of the issues that arise in these families are migration-related, Qin said. All the Chinese children in the larger sample had immigrant parents, she said, while almost none of the European-American kids did.

"My co-authors and I are not pathologizing Chinese kids and saying, 'Oh my God, Chinese kids are oppressed,'" Qin said. "The findings really point to immigration and the challenges created by migration in families."

"When children are caught in between their parents' old way of parenting and being and culture and the new in the U.S., then that can be very, very tough for children in a variety of ways."

Finding a middle ground

Not all Chinese parents take the "tiger" approach, of course. In fact, Qin's in-depth interviews, to be published in an upcoming issue of the journal New Directions for Child and Adolescent Development, found that even strict "tiger parenting" is not black and white. The parents of the kids in the study worried about their children's health and happiness, and expressed sympathy when the children were overworked.

"They have a lot of internal conflict," Qin said of these parents. "They want them to be successful in the new land, and they want them to be healthy."

Fortunately, both are possible, Qin said. In a 2008 paper, Qin compared high-achieving Chinese-American students who were distressed with Chinese-American high-achievers who were mentally healthy. She found that the teens in families where parents take a strict "tiger mom" approach were the distressed ones. The high-achieving Chinese-American kids with more flexible parents did just as well in school, but were happy, too.

That's the important message for all parents, "tiger" or not, Qin said. It's not a problem to have high expectations for your child, she said. You just have to communicate those expectations with love and warmth.

"You can have a happy child with high achievement," Qin said. "A lot of families do have that."

You can follow LiveScience?senior writer Stephanie Pappas on Twitter @sipappas. Follow LiveScience for the latest in science news and discoveries on Twitter @livescience?and on Facebook.

Source: http://us.rd.yahoo.com/dailynews/rss/diseases/*http%3A//news.yahoo.com/s/livescience/20120120/sc_livescience/studytigerparentingtoughonkids

jack wagner matt jones snow white and the huntsman trailer snow white and the huntsman trailer sexiest man alive kentucky basketball bob costas

Check Out DRIVE Automotive :: DeKalb County Online

What does D.R.I.V.E. stand for in DRIVE Automotive? Discover Reputable Independent Vehicle Experts, and they mean it!? The quality ASE (Automotive Service Excellence) certified technicians at Drive Automotive utilize today?s latest automotive technology and are equipped to handle all major and minor repairs on all vehicles. It is a valuable yardstick by which to measure the knowledge and skills of individual technicians as well as the commitment to quality of the repair facility employing ASE-Certified professionals.

Drive Automotive is dedicated to the best, continual training and education available. They hold a Master status with Automotive Service Excellence, for all makes and models, as well as original equipment manufacture certifications for Toyota, Mazda, Nissan, and even O.E.M. Hybrid certifications. Vern Kuhlman, owner of D.R.I.V.E. Automotive, holds Master Diagnostic Technician Certifications with the Toyota company. This is the highest level of achievement given by Toyota, and as far as they know he is the only Technician of this caliber in the surrounding area.

DRIVE Automotive is proud to be a NAPA AutoCare Center. NAPA AutoCare is not a franchise, but rather, a quality standard where independent repair business owners are invited to join based upon their community reputation, integrity, qualifications and expertise.

Drive Automotive is not new to the business of providing automotive service, and has been responsible for providing outstanding customer service for over thirty years. Their specialty is providing customers with the most complete, technologically advanced automotive repair available at a fair price. From maintenance, accessories, to major repairs, their goal is to provide you with one place to meet all your automotive needs and services. Regular customers appreciate the honesty, dedication, and value system they have implemented as the building blocks of the business.

Drive Automotive is located at 849 South Fourth St. in DeKalb. Visit their website now for more information as well as great special deals!

Source: http://dekalbcountyonline.com/check-out-drive-automotive/

numerology the game hue jackson new hampshire primary alabama football coachella 2012 line up lsu